{
  "retracted": false,
  "timestamp": 1522368000000,
  "updates": [
    {
      "timestamp": 1574806819768,
      "identifier": {
        "doi": "10.1016/j.ejps.2018.01.012"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.ejps.2017.10.036"
  },
  "journal": "European Journal of Pharmaceutical Sciences",
  "publisher": "Elsevier BV",
  "title": "Corrigendum to “Co-delivery of sorafenib and siVEGF based on mesoporous silica nanoparticles for ASGPR mediated targeted HCC therapy” [Eur. J. Pharm. Sci. 111 (1 January 2018) 492–502]"
}
